©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 7, 2010; 16(45): 5732-5738
Published online Dec 7, 2010. doi: 10.3748/wjg.v16.i45.5732
Published online Dec 7, 2010. doi: 10.3748/wjg.v16.i45.5732
Table 1 Characteristics of patients, relatives and control group subjects n (%)
| CD (n = 64) | CD relatives (n = 25) | UC (n = 63) | UC relatives (n = 28) | Control (n = 34) | |
| Sex | |||||
| Male | 28 (43.8) | 9 (36.0) | 32 (50.8) | 11 (39.3) | 15 (44.1) |
| Female | 36 (56.2) | 16 (64.0) | 31 (49.2) | 17 (60.7) | 19 (55.9) |
| Age (yr, mean ± SD) | 37.93 ± 14.01 | 32.12 ± 14.31 | 38.74 ± 13.13 | 35.35 ± 17.07 | 38.58 ± 15.09 |
| Disease duration (yr, mean ± SD) | 4.37 ± 3.61 | 4.03 ± 3.66 | |||
| Disease location (CD) | |||||
| Colon | 2 (3.1) | ||||
| Ileum | 26 (40.6) | ||||
| Ileocolonic | 36 (56.3) | ||||
| Disease location (UC) | |||||
| Proctitis | 9 (14.3) | ||||
| Distal involvement | 24 (38.1) | ||||
| Left colon invol | 9 (14.3) | ||||
| Diffuse | 2 (3.2) | ||||
| Pancolitis | 19 (30.2) | ||||
| Disease type (CD) | |||||
| Stricturing | 7 (10.9) | ||||
| Penetrating | 6 (9.4) | ||||
| Inflammatory | 51 (79.7) | ||||
| Medications (for CD and UC) | |||||
| No medication | 5 (7.8) | 5 (7.9) | |||
| 5-ASA | 57 (89.06) | 57 (90.4) | |||
| Steroids | 5 (7.8) | 5 (7.9) | |||
| AZA | 13 (20.3) | 8 (12.6) | |||
| Antibiotics | 1 (1.6) | 3 (4.7) |
- Citation: Demirsoy H, Ozdil K, Ersoy O, Kesici B, Karaca C, Alkim C, Akbayir N, Erdem LK, Onuk MD, Beyzadeoglu HT. Anti-pancreatic antibody in Turkish patients with inflammatory bowel disease and first-degree relatives. World J Gastroenterol 2010; 16(45): 5732-5738
- URL: https://www.wjgnet.com/1007-9327/full/v16/i45/5732.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i45.5732